Business Wire

FL-FUN-BRANDS

Share
World Famous Soccer Star Neymar Junior Joins Forces With Fun Brands and Enters the Cocktails and Mocktails Business With His Own Brand

Neymar da Silva Santos Júnior, known as one of the best soccer players in the world, joins forces with Fun Brands, a Miami, Florida-based beverage company, to announce a new collaborative venture of innovative, all-natural spirit- and wine-based cocktails and zero alcohol mocktails launching in Brazil later this year.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240415201897/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

World Famous Soccer Star Neymar Junior Announces Collaborative Venture With Fun Brands to Enter Cocktail and Mocktail Business With Own Brand (Photo: Business Wire)

“This is a great opportunity for me to celebrate in a new way with my fans worldwide, creating possibilities for connection beyond soccer, which is my life,” highlighted the All-star. “I want to share the flavors of Brazil that I love the most with my soccer fans at home and around the world in a different and irreverent way. The idea of also offering non-alcoholic beverages greatly attracted me to the venture.”

For Fun Brands, the moment has a special flavor. It is the unique opportunity to present the market with an innovative line of low alcohol cocktails and zero alcohol mocktails through a Brazilian brand with global reach, brought to life in partnership with Neymar Junior’s vision for beverages that speak to his lifestyle and tastes. Fun Brands develops low-sugar, low-calorie beverages with all-natural ingredients.

“The partnership with Neymar Junior will focus on the ‘Tastes of Brazil,’ a country of incredible flavors, and globalize in collaboration with a large company in this segment,” said the Founder & CEO of Fun Brands, Joe Peleg. The new beverage brand will roll out with low and no-alcohol varieties first in Brazil and thereafter in strategic global markets.

Follow along and stay up to date on the launch of Neymar Junior’s beverages via www.funbrands.fun.

About NR Sports Ltd.

NR Sports Ltd. is a career management company headquartered in Sao Paulo, Brazil, that specializes in image management relating to the careers of Neymar Junior and Brazil’s Olympic Gold Medalist Thiago Braz. The company was founded in 2006 by Neymar Junior’s parents.

About Fun Brands

Fun Brands is a US beverage group that is developing and will market Neymar’s alcoholic and non-alcoholic beverages. The company is affiliated with and owned by beverage and media executives and investors with expertise in beverage design and packaging. Fun Brands’ global media partner and shareholder, Icon International, Inc., will collaborate on the promotion and marketing with Neymar’s media partners. For more information, please email info@funbrands.fun

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240415201897/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Board Unveils New Foresight and Signals Products: Revolutionizing Business Planning with AI and Economic Intelligence19.2.2025 15:00:00 CET | Press release

Board, the leading Enterprise Planning Platform, is transforming the way businesses anticipate and adapt to economic shifts with today’s announcement of Board Foresight and Board Signals. These cutting-edge solutions, developed as a result of Board’s recent acquisition of Prevedere, empower enterprises with real-time economic indicators, predictive analytics, and the expertise of Board’s in-house economists—all backed by exclusive access to over 5 million global datasets. This release marks a huge step forward in completing Board’s product vision. By harnessing the power of macroeconomic intelligence, the Board Enterprise Planning Platform now enables more comprehensive, collaborative, and continuous planning capabilities than ever before. Board Foresight and Signals give business leaders the ability to look beyond internal historical data, forecast with greater accuracy, scenario plan with more agility, and make strategic decisions with confidence in an increasingly volatile world. Bo

PPG, PPG Foundation invested $18.4 million in communities worldwide in 202419.2.2025 15:00:00 CET | Press release

PPG (NYSE:PPG) and the PPG Foundation today announced that they invested $18.4 million worldwide in 2024, an increase of $900,000 over 2023. The 2024 funding supported more than 400 community partners and programs that focus on advancing education and delivering community sustainability while encouraging PPG employee volunteerism. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219834296/en/ PPG and the PPG Foundation invested $18.4 million worldwide in 2024 to programs that focus on advancing education and delivering community sustainability while encouraging PPG employee volunteerism. (Photo: Business Wire) “Around the world, PPG’s 2024 community engagement investments aimed to inspire students and aspiring STEM leaders, beautify neighborhoods and give our employees meaningful ways to give back,” said Malesia Dunn, executive director, PPG Foundation and corporate global social responsibility. “We’re focused on creating b

HSBC Continental Europe: 2024 Annual and Second Half Results19.2.2025 14:40:00 CET | Press release

Regulatory News: On 18 February 2025, HSBC Continental Europe’s Board of Directors reviewed the second half year results and approved the consolidated financial statements for 2024. At HSBC, our ambition is to be the preferred and most trusted international financial partner for our clients. In Continental Europe, we are focused on serving corporate and institutional clients, with a particular focus on connecting them to international markets, financing and facilitating trade within Europe and between Europe and the rest of the world. We also serve international high and ultra-high net worth clients of the HSBC Group through our private banking business in Luxembourg. In the second half of 2024, we accelerated our strategy by signing an agreement to sell our private banking business in Germany and a Memorandum of Understanding for the potential sale of our life insurance business in France1. Our results in 2024 reflected growth in wholesale transaction banking and financing, offset by

Parse Biosciences Launches 5 Million Cell Evercode WT Penta Kit for Single Cell Sequencing19.2.2025 14:15:00 CET | Press release

The most scalable and high-resolution single cell solution available Parse Biosciences, the leader in high-throughput single cell sequencing, today announced the launch of Evercode™ WT Penta and Penta 384, the first single cell RNA sequencing kits to profile 5 million cells and 384 samples in a single run. Evercode Penta and Penta 384 will begin shipping to customers the week of March 17. Scaling up single cell experiments—processing millions of cells instead of thousands—has revolutionized the way researchers study development, disease, and cellular heterogeneity. In 2021, Parse set a new benchmark for scalability of single cell experiments with the release of Evercode™ WT Mega, the industry’s highest throughput kit, enabling researchers to push the boundaries of their experimental designs. With the release of Evercode WT Penta, Parse continues to redefine the limits of single cell research. Penta is the only technology offering fixation and truly unbiased discovery of novel gene expr

Celerion Expands UK Phase 1 Clinical Research Operations With New Agreement to Relocate to Queen’s University Belfast’s iREACH Health – Clinical Research Innovation Center19.2.2025 14:00:00 CET | Press release

Celerion, a global leader in early clinical research, proudly announces a new agreement to relocate its U.K. Phase 1 clinical research operations to iREACH Health. This state-of-the-art clinical research center, led by Queen’s University Belfast, in partnership with the Belfast Health and Social Care Trust, is set to become a cornerstone of Northern Ireland’s life sciences innovation ecosystem upon its early 2027 completion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219467591/en/ Set to complete in 2027, the state-of-the-art iREACH Health clinical research center is set to become a cornerstone of Northern Ireland's life sciences landscape. As part of this development, Celerion will relocate its U.K. Phase 1 clinical research operations to the facility, positioning it at the forefront of clinical research innovation. (Photo: Business Wire) Celerion’s Belfast clinic has a history of clinical research excellence spannin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye